Clinical Trial: A multiple-dose, randomized, multicenter, phase II clinical trial to evaluate the efficacy, safety, and pharmacokinetic characteristics of SR604 Injection in patients with von Willebrand disease (China)

Posted On: 2026-08-10

China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multiple-dose, randomized, multicenter, phase II clinical trial to evaluate the efficacy, safety, and pharmacokinetic characteristics of SR604 Injection in patients with von Willebrand disease'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129725

Registration Time: 2026/08/09

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Soochow University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=324353

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A multiple-dose, randomized, multicenter, phase II clinical trial to evaluate the efficacy, safety, and pharmacokinetic characteristics of SR604 Injection in patients with von Willebrand disease (China)